J. Howbert

发表

Forecasting Seizures Using Intracranial EEG Measures and SVM in Naturally Occurring Canine Epilepsy

Joost B. Wagenaar, V. Cherkassky, B. Litt, 2015, PloS one.

Forecasting Seizures in Dogs with Naturally Occurring Epilepsy

Brian Litt, Gregory A. Worrell, Kent Leyde, 2014, PloS one.

Species differences in affinities of non-peptide antagonists for substance P receptors.

J. Howbert, B. Gitter, D. C. Waters, 1991, European journal of pharmacology.

Inhibition of protein kinase C by calphostin C is light-dependent.

J. Howbert, I. Takahashi, T. Tamaoki, 1991, Biochemical and biophysical research communications.

Potent inhibition of interleukin 1 beta-mediated human melanoma (A375.6) lysis by corticosteroids, staurosporine, and tilorone.

R. A. Archer, J. Howbert, R. Schultz, 1989, Immunopharmacology and immunotoxicology.

A clinical study of bronchiolar carcinoma. A clue to unicentricity or multicentricity.

J. Howbert, J. E. Hansen, J. Hawkins, 1963, The American review of respiratory disease.

Interleukin-6 secretion from human astrocytoma cells induced by substance P

J. Howbert, B. Gitter, A. Glasebrook, 1994, Journal of Neuroimmunology.

Tachykinin receptor antagonists inhibit hyperpnea-induced bronchoconstriction in guinea pigs.

J. Howbert, I. Rodger, J. Solway, 1993, The Journal of clinical investigation.

Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.

J. Howbert, P. Threlkeld, B. Gitter, 1995, The Journal of pharmacology and experimental therapeutics.

Evidence for mitochondrial localization of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea in human colon adenocarcinoma cells.

J. Howbert, P. Houghton, J. Houghton, 1990, Cancer research.

Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat.

J. Howbert, B. Gitter, R. Couture, 1993, European journal of pharmacology.

(R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake.

J. Howbert, D. Wong, R. Fuller, 1995, Life sciences.

Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain

J. Howbert, D. Wong, R. Fuller, 1995, Neurochemistry International.

Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P.

J. Howbert, B. Gitter, D. Regoli, 1991, Biochemical and biophysical research communications.

Evidence for Mitochondria! Localization of yV-(4-Methylphenylsulfonyl)-jY'-(4-chlorophenyl)urea in Human Colon Adenocarcinoma Cells

J. Howbert, P. Houghton, F. Bailey, 2006 .

Evaluation of N-(5-indanylsulfonyl)-N′-(4-chlorophenyl)-urea against xenografts of pediatric rhabdomyosarcoma

J. Howbert, P. Houghton, J. Houghton, 2004, Cancer Chemotherapy and Pharmacology.

Studies on the cellular pharmacology of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)-urea.

J. Howbert, P. Houghton, J. Houghton, 1990, Biochemical pharmacology.

Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.

J. Howbert, K. Rasmussen, J. F. Czachura, 1993, The Journal of pharmacology and experimental therapeutics.

A Simple Approach to Adjust for Case-Mix when Comparing Institutional Cesarean Birth Rates.

J. Howbert, V. Souter, Ellen Kauffman, 2019, American journal of perinatology.

[3H]LY303870, a Novel Nonpeptide Radioligand for the NK‐1 Receptor

J. Howbert, D. Gehlert, B. Gitter, 1996, Journal of neurochemistry.

3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists.

J. Howbert, P. Hipskind, S. Iyengar, 1996, Journal of medicinal chemistry.

Augments ADCC VTX-2337 Is a Novel TLR 8 Agonist That Activates NK Cells and Updated

J. Howbert, V. Maino, R. Hershberg, 2012 .

Cancer Therapy : Preclinical VTX-2337 Is a Novel TLR 8 Agonist That Activates NK Cells and Augments ADCC

J. Howbert, V. Maino, R. Hershberg, 2012 .

VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC

J. Howbert, V. Maino, R. Hershberg, 2011, Clinical Cancer Research.

Of monkeys and men: vervets and the genetics of human-like behaviors.

J. Howbert, R. Palmour, F. Ervin, 1997, American journal of human genetics.

Inhibition of A9 and A10 dopamine cells by the cholecystokinin‐B antagonist LY262691: Mediation through feedback pathways from forebrain sites

J. Howbert, K. Rasmussen, M. Stockton, 1993, Synapse.

Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity.

J. Howbert, K. Rasmussen, J. F. Czachura, 1991, European journal of pharmacology.

INSIGHTSFROM MODEL SYSTEMS OfMonkeysandMen:Vervets andtheGenetics ofHuman-Like Behaviors

J. Howbert, R. Palmour, Eastern Caribbean, 1997 .

Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.

J. Howbert, B. Neubauer, R. Merriman, 1992, The Journal of urology.